Abstract
In this issue of Molecular Cell, Gambi, Boccalatte, Hernaez, et al.1 apply multiomics followed by genetic engineering to define then characterize epigenetic hubs that regulate processes crucial for T-ALL and use this insight to offer new avenues for therapeutic targeting.
Original language | English (US) |
---|---|
Pages (from-to) | 1-2 |
Number of pages | 2 |
Journal | Molecular cell |
Volume | 85 |
Issue number | 1 |
DOIs |
|
State | Published - Jan 2 2025 |
Funding
The Yue lab is supported by is supported by United States National Institute of Health grants R35GM124820 and R01HG011207.
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology